Sir.—I read with interest the report by Huseman and Torkelson1 concerning the development of pseudotumor cerebri following treatment of hypothyroidism and would like to describe a patient who experienced a course similar to that of the authors' second patient.
Patient Report.—A girl with primary hypothyroidism was referred to the endocrine clinic. She was 6½ years old and presented with linear growth failure. Her thyroxine level was 0.5 μg/dL, her thyroid-stimulating hormone (TSH) level was greater than 100 μU/mL, and her bone age was 2¾ years. She initially received a dose of 0.05 mg of levothyroxine sodium, which was increased to 0.1 mg over one month. Six weeks into treatment she returned with complaints of headaches and visual disturbance. On funduscopic examination, papilledema was recognized. Skull x-ray films showed enlargement of the sella turcica. A computed tomographic scan confirmed enlargement of the sella without evidence of a tumor.
ROHN R. Pseudotumor Cerebri Following Treatment of Hypothyroidism. Am J Dis Child. 1985;139(8):752. doi:10.1001/archpedi.1985.02140100014015
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: